Washington, D.C. — Senator Ted Budd (R-N.C.) released the following statement after President Trump signed an executive order that would reschedule marijuana from a Schedule I drug to a lower classification, easing federal restrictions on the substance: 

Washington, D.C. — Senator Ted Budd (R-N.C.), a member of the Senate Armed Services Committee (SASC), voted in favor of passage of the Fiscal Year (FY) 2026 National Defense Authorization Act (NDAA) today. The bill includes numerous provisions to improve readiness and quality of life for our troops, increase funding for North Carolina military installations, deter China, and strengthen alliances abroad. The defense package is now headed to the President’s desk to be signed into law. 

U.S. Senator Ted Budd (R-N.C.) issued the following statement after the U.S. Senate passed legislation that puts the Lumbee Tribe of North Carolina on the path to receive the full federal benefits they have long been unfairly denied.

Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and Maggie Hassan (D-N.H.) introduced the bipartisan Biosimilar Inspection Modernization Act, legislation that would make prescription drugs more accessible and affordable by updating and improving the Food and Drug Administration’s (FDA) inspection processes for facilities manufacturing biosimilar medicines

Washington, D.C. — U.S. Senators Ted Budd (R-N.C.) and John Fetterman (D-Pa.) introduced the National Programmable Cloud Laboratories Network Act to create a national network of six remotely accessible programmable cloud laboratories (PCLs) for academic research, led by the National Science Foundation (NSF). By joining existing laboratory data processing power together, this bill would help researchers use their time and financial resources more effectively through automation and integration of large data sets.